ARL6IP6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.193600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.547800E-01
Normal-vs-Stage2
9.137200E-01
Normal-vs-Stage3
3.799100E-03
Normal-vs-Stage4
8.418200E-01
Stage1-vs-Stage2
2.580400E-01
Stage1-vs-Stage3
2.378400E-01
Stage1-vs-Stage4
2.681400E-01
Stage2-vs-Stage3
9.338200E-02
Stage2-vs-Stage4
6.982600E-01
Stage3-vs-Stage4
1.942820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.955600E-01
Normal-vs-AfricanAmerican
7.902600E-01
Normal-vs-Asian
8.233800E-01
Caucasian-vs-AfricanAmerican
9.521000E-01
Caucasian-vs-Asian
8.583200E-01
AfricanAmerican-vs-Asian
9.570400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.784600E-01
Normal-vs-Female
5.081200E-01
Male-vs-Female
7.896000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.099800E-01
Normal-vs-Age(41-60Yrs)
4.105000E-01
Normal-vs-Age(61-80Yrs)
6.039200E-01
Normal-vs-Age(81-100Yrs)
5.928600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.216800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.580400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.888200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.340200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.484000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.784400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.308800E-01
Normal-vs-Daily Drinker
6.720000E-01
Normal-vs-Weekly Drinker
2.916000E-01
Normal-vs-Occasional Drinker
1.681240E-01
Normal-vs-Social Drinker
5.593000E-01
Non Drinker-vs-Daily Drinker
6.687400E-01
Non Drinker-vs-Weekly Drinker
2.438800E-01
Non Drinker-vs-Occasional Drinker
1.732350E-01
Non Drinker-vs-Social Drinker
6.015800E-01
Daily Drinker-vs-Weekly Drinker
4.468800E-01
Daily Drinker-vs-Occasional Drinker
5.523700E-02
Daily Drinker-vs-Social Drinker
8.545400E-01
Weekly Drinker-vs-Occasional Drinker
1.520180E-02
Weekly Drinker-vs-Social Drinker
5.576800E-01
Occasional Drinker-vs-Social Drinker
5.922000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.276220E-01
Normal-vs-Grade 2
6.916300E-02
Normal-vs-Grade 3
9.172300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.763920E-02
Grade 1-vs-Grade 3
4.821300E-04
Grade 1-vs-Grade 4
1.276220E-01
Grade 2-vs-Grade 3
7.520400E-02
Grade 2-vs-Grade 4
6.916300E-02
Grade 3-vs-Grade 4
9.172300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.312600E-01
Normal-vs-NonDiabetic
5.472800E-01
Diabetic-vs-NonDiabetic
1.002620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.756000E-01
Normal-vs-NoPancreatitis
8.129400E-01
Pancreatitis-vs-NoPancreatitis
3.860600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.341200E-01
Normal-vs-N1
9.195400E-01
N0-vs-N1
1.516180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.222000E-01
Normal-vs-TP53-NonMutant
3.941200E-01
TP53-Mutant-vs-TP53-NonMutant
3.21089999999469E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
